N. Niu

发表

Linking genomic reorganization to tumor initiation via the giant cell cycle

R. Bast, M. Hung, Jianhua Zhang, 2016, Oncogenesis.

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.

M. Slovak, C. Sawyers, D. Arber, 2003, Blood.

WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.

S. Groshen, A. Reles, M. Press, 1997, The American journal of pathology.

Effect of Mutational Inactivation of Tyrosine Kinase Activity on BCR/ABL-Induced Abnormalities in Cell Growth and Adhesion in Human Hematopoietic Progenitors

J. Yee, Harjeet Singh, N. Niu, 2004, Cancer Research.

Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study

H. Xu, Xinyu Zheng, J. Liu, 2022, medRxiv.

following imatinib mesylate treatment myelogenous leukemia patients in complete cytogenetic remission Persistence of malignant hematopoietic progenitors in chronic

M. Slovak, C. Sawyers, D. Arber, 2013 .

Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells

I. Mercado-uribe, N. Niu, Na Niu, 2017, Oncogene.

p53 mutations and expression in breast carcinoma in situ.

M. Press, N. Niu, J. Lukas, 2000, The American journal of pathology.

Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study.

P. Nowell, M. Slovak, C. Sawyers, 2002, Blood.

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.

M. Slovak, C. Sawyers, D. Arber, 2003, Blood.